Is the Inflation Reduction Act a Good Idea?

The FDA Commissioner, Dr. Rob Kaleb, was interviewed by CNN's John Sutter at a JPMorgan event on Monday night. The topic of conversation was the congressional report that had come out the week prior and criticized the FDA for its relationship with Biogen in the way it reviewed Adjoham. "I get insulted when people say ... we're not going to work on a cure for cancer because of the inflation reduction act," Sutter says.